1982•PubMedRequires access

Leukapheresis in leukemia.

H E Mallard

Open publisher page 4 citations

Abstract

Leukapheresis by continuous flow centrifugation was employed in the management of both acute and chronic leukemia. Cytareduction is an effective method of preventing leukostasis in acute leukemia and reducing leukocytosis in chronic leukemia. A report of 55 leukapheresis experiences with 32 patients is described. A case report of a 49-year-old female with a 13-year history of hairy cell leukemia who underwent intensive leukapheresis over seven months is given. Therapeutic cell depletions do not effect the eventual outcome of the disease but they do have a therapeutic role in the management of leukemia as a adjunct to other treatments.

About this research paper

What this paper is about

Leukapheresis by continuous flow centrifugation was employed in the management of both acute and chronic leukemia. Cytareduction is an effective method of preventing leukostasis in acute leukemia and reducing leukocytosis in chronic leukemia. A report of 55 leukapheresis experiences with 32 patients is described. A case report of a 49-year-old female with a 13-year history of hairy cell leukemia who underwent intensive leukapheresis over seven months is given. Therapeutic cell depletions do not effect the eventual outcome of the disease but they do have a therapeutic role in the management of leukemia as a adjunct to other treatments.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Leukapheresis by continuous flow centrifugation was employed in the management of both acute and chronic leukemia. Cytareduction is an effective method of preventing leukostasis in acute leukemia and reducing leukocytosis in chronic leukemia. A report of 55 leukapheresis experiences with 32 patients is described. A case report of a 49-year-old female with a 13-year history of hairy cell leukemia who underwent intensive leukapheresis over seven months is given. Therapeutic cell depletions do not effect the eventual outcome of the disease but they do have a therapeutic role in the management of leukemia as a adjunct to other treatments.

Key concepts: Leukapheresis, Leukostasis, Medicine, Leukocytosis, Leukemia, Acute leukemia, Intensive care medicine, Immunology

Related papers

Back to paper searchBrowse research topicsOriginal source
Leukapheresis in leukemia. — Research Paper | ScholarLens